Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

p54nrb/NONO regulates lipid metabolism and breast cancer growth through SREBP-1A

Oncogene volume 35, pages 1399–1410 (2016)Cite this article

Subjects

Abstract

Dysregulation of lipid metabolism is common in breast cancer. However, the underlying mechanisms remain elusive and the contribution of aberrant lipid metabolism to the malignant phenotypes of breast cancer is poorly understood. Here, we show that the nuclear protein p54nrb/Nono is highly expressed in breast cancer tissues as compared with the adjacent normal tissues in human patients. To determine the functions of p54nrb in breast cancer, we performed a biochemical screen and identified SREBP-1a, a master activator for genes involved in lipid biosynthesis, as a novel interacting protein of p54nrb. In human breast cancer tissues, the levels of p54nrb and SREBP-1a proteins were positively correlated with each other. Our biochemical analyses showed that the conserved Y267 residue of p54nrb was required for its binding to the nuclear form of SREBP-1a. Interestingly, p54nrb binding to nuclear SREBP-1a caused an increase of nuclear SREBP-1a protein stability. As a result, p54nrb stimulates SREBP-1-meidated transcription of lipogenic genes and lipid production in breast cancer cells. Moreover, both p54nrb and SREBP-1a were required for breast cancer cell growth in vitro, and p54nrb binding to nuclear SREBP-1a was also critical for breast tumor development in vivo. Together, we conclude that p54nrb is a novel regulator of SREBP-1a in the nucleus, and our data suggest that p54nrb regulation of SREBP-1a supports the increased cellular demand of lipids for breast cancer growth. Thus, the SREBP pathway may represent a novel target for treating breast cancer.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  1. Siegel R, Naishadham D, Jemal A . Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11–30.

    Article  Google Scholar 

  2. Ferlay J, Soerjomataram II, Dikshit R, Eser S, Mathers C, Rebelo M et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2014; 136: E359–E386.

    Article  Google Scholar 

  3. Hanahan D, Weinberg RA . Hallmarks of cancer: the next generation. Cell 2011; 144: 646–674.

    Article  CAS  Google Scholar 

  4. Tennant DA, Duran RV, Gottlieb E . Targeting metabolic transformation for cancer therapy. Nat Rev Cancer 2010; 10: 267–277.

    Article  CAS  Google Scholar 

  5. Furuta E, Pai SK, Zhan R, Bandyopadhyay S, Watabe M, Mo YY et al. Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1. Cancer Res 2008; 68: 1003–1011.

    Article  CAS  Google Scholar 

  6. Lu S, Archer MC . Sp1 coordinately regulates de novo lipogenesis and proliferation in cancer cells. Int J Cancer 2010; 126: 416–425.

    Article  CAS  Google Scholar 

  7. Park J, Morley TS, Kim M, Clegg DJ, Scherer PE . Obesity and cancer–mechanisms underlying tumour progression and recurrence. Nat Rev Endocrinol 2014; 10: 455–465.

    Article  CAS  Google Scholar 

  8. Shav-Tal Y, Zipori D . PSF and p54(nrb)/NonO–multi-functional nuclear proteins. FEBS Lett 2002; 531: 109–114.

    Article  CAS  Google Scholar 

  9. Zhang Z, Carmichael GG . The fate of dsRNA in the nucleus: a p54(nrb)-containing complex mediates the nuclear retention of promiscuously A-to-I edited RNAs. Cell 2001; 106: 465–475.

    Article  CAS  Google Scholar 

  10. Hata K, Nishimura R, Muramatsu S, Matsuda A, Matsubara T, Amano K et al. Paraspeckle protein p54nrb links Sox9-mediated transcription with RNA processing during chondrogenesis in mice. J Clin Invest 2008; 118: 3098–3108.

    Article  CAS  Google Scholar 

  11. Ishiguro H, Uemura H, Fujinami K, Ikeda N, Ohta S, Kubota Y . 55 kDa nuclear matrix protein (nmt55) mRNA is expressed in human prostate cancer tissue and is associated with the androgen receptor. Int J Cancer 2003; 105: 26–32.

    Article  CAS  Google Scholar 

  12. Schiffner S, Zimara N, Schmid R, Bosserhoff AK . p54nrb is a new regulator of progression malignant melanoma. Carcinogenesis 2011; 32: 1176–1182.

    Article  CAS  Google Scholar 

  13. Liu PY, Erriquez D, Marshall GM, Tee AE, Polly P, Wong M et al. Effects of a novel long noncoding RNA, lncUSMycN, on N-Myc expression and neuroblastoma progression. J Natl Cancer Inst 2014; 106: pii.

  14. Pavao M, Huang YH, Hafer LJ, Moreland RB, Traish AM . Immunodetection of nmt55/p54nrb isoforms in human breast cancer. BMC Cancer 2001; 1: 15.

    Article  CAS  Google Scholar 

  15. Yokoyama C, Wang X, Briggs MR, Admon A, Wu J, Hua X et al. SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell 1993; 75: 187–197.

    Article  CAS  Google Scholar 

  16. Zhao X, Xiaoli, Zong H, Abdulla A, Yang ES, Ji JY et al. Inhibition of SREBP transcriptional activity by a boron-containing compound improves lipid homeostasis in diet-induced obesity. Diabetes 2014; 63: 2464–2473.

    Article  Google Scholar 

  17. Shao W, Espenshade PJ . Expanding Roles for SREBP in Metabolism. Cell Metab 2012; 16: 414–419.

    Article  CAS  Google Scholar 

  18. Shimomura I, Shimano H, Horton JD, Goldstein JL, Brown MS . Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells. J Clin Invest 1997; 99: 838–845.

    Article  CAS  Google Scholar 

  19. Horton JD, Goldstein JL, Brown MS . SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 2002; 109: 1125–1131.

    Article  CAS  Google Scholar 

  20. Menendez JA, Lupu R . Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 2007; 7: 763–777.

    Article  CAS  Google Scholar 

  21. Li JN, Mahmoud MA, Han WF, Ripple M, Pizer ES . Sterol regulatory element-binding protein-1 participates in the regulation of fatty acid synthase expression in colorectal neoplasia. Exp Cell Res 2000; 261: 159–165.

    Article  CAS  Google Scholar 

  22. Heemers H, Maes B, Foufelle F, Heyns W, Verhoeven G, Swinnen JV . Androgens stimulate lipogenic gene expression in prostate cancer cells by activation of the sterol regulatory element-binding protein cleavage activating protein/sterol regulatory element-binding protein pathway. Mol Endocrinol 2001; 15: 1817–1828.

    Article  CAS  Google Scholar 

  23. Yang Y, Morin PJ, Han WF, Chen T, Bornman DM, Gabrielson EW et al. Regulation of fatty acid synthase expression in breast cancer by sterol regulatory element binding protein-1c. Exp Cell Res 2003; 282: 132–137.

    Article  CAS  Google Scholar 

  24. Guo D, Prins RM, Dang J, Kuga D, Iwanami A, Soto H et al. EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy. Sci Signal 2009; 2: ra82.

    Article  Google Scholar 

  25. Freed-Pastor WA, Mizuno H, Zhao X, Langerod A, Moon SH, Rodriguez-Barrueco R et al. Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway. Cell 2012; 148: 244–258.

    Article  CAS  Google Scholar 

  26. Yecies JL, Zhang HH, Menon S, Liu S, Yecies D, Lipovsky AI et al. Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways. Cell Metab 2011; 14: 21–32.

    Article  CAS  Google Scholar 

  27. Williams KJ, Argus JP, Zhu Y, Wilks MQ, Marbois BN, York AG et al. An essential requirement for the SCAP/SREBP signaling axis to protect cancer cells from lipotoxicity. Cancer Res 2013; 73: 2850–2862.

    Article  CAS  Google Scholar 

  28. Guo D, Bell EH, Mischel P, Chakravarti A . Targeting SREBP-1-driven lipid metabolism to treat cancer. Curr Pharm Des 2014; 20: 2619–2626.

    Article  CAS  Google Scholar 

  29. Amelio AL, Miraglia LJ, Conkright JJ, Mercer BA, Batalov S, Cavett V et al. A coactivator trap identifies NONO (p54nrb) as a component of the cAMP-signaling pathway. Proc Natl Acad Sci USA 2007; 104: 20314–20319.

    Article  CAS  Google Scholar 

  30. Ishitani K, Yoshida T, Kitagawa H, Ohta H, Nozawa S, Kato S . p54nrb acts as a transcriptional coactivator for activation function 1 of the human androgen receptor. Biochem Biophys Res Commun 2003; 306: 660–665.

    Article  CAS  Google Scholar 

  31. Passon DM, Lee M, Rackham O, Stanley WA, Sadowska A, Filipovska A et al. Structure of the heterodimer of human NONO and paraspeckle protein component 1 and analysis of its role in subnuclear body formation. Proc Natl Acad Sci USA 2012; 109: 4846–4850.

    Article  CAS  Google Scholar 

  32. Kuwahara S, Ikei A, Taguchi Y, Tabuchi Y, Fujimoto N, Obinata M et al. PSPC1, NONO, and SFPQ are expressed in mouse Sertoli cells and may function as coregulators of androgen receptor-mediated transcription. Biol Reprod 2006; 75: 352–359.

    Article  CAS  Google Scholar 

  33. Kuhnert A, Schmidt U, Monajembashi S, Franke C, Schlott B, Grosse F et al. Proteomic identification of PSF and p54(nrb) as TopBP1-interacting proteins. J Cell Biochem 2012; 113: 1744–1753.

    CAS  Google Scholar 

  34. Zhao X, Feng D, Wang Q, Abdulla A, Xie XJ, Zhou J et al. Regulation of lipogenesis by cyclin-dependent kinase 8-mediated control of SREBP-1. J Clin Invest 2012; 122: 2417–2427.

    Article  CAS  Google Scholar 

  35. Sundqvist A, Bengoechea-Alonso MT, Ye X, Lukiyanchuk V, Jin J, Harper JW et al. Control of lipid metabolism by phosphorylation-dependent degradation of the SREBP family of transcription factors by SCF(Fbw7). Cell Metab 2005; 1: 379–391.

    Article  CAS  Google Scholar 

  36. Medes G, Thomas A, Weinhouse S . Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro. Cancer Res 1953; 13: 27–29.

    CAS  Google Scholar 

  37. Nieva C, Marro M, Santana-Codina N, Rao S, Petrov D, Sierra A . The lipid phenotype of breast cancer cells characterized by Raman microspectroscopy: towards a stratification of malignancy. PLoS One 2012; 7: e46456.

    Article  CAS  Google Scholar 

  38. Rysman E, Brusselmans K, Scheys K, Timmermans L, Derua R, Munck S et al. De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation. Cancer Res 2010; 70: 8117–8126.

    Article  CAS  Google Scholar 

  39. Currie E, Schulze A, Zechner R, Walther TC, Farese RV Jr. . Cellular fatty acid metabolism and cancer. Cell Metab 2013; 18: 153–161.

    Article  CAS  Google Scholar 

  40. Kuhajda FP . Fatty acid synthase and cancer: new application of an old pathway. Cancer Res 2006; 66: 5977–5980.

    Article  CAS  Google Scholar 

  41. Milgraum LZ, Witters LA, Pasternack GR, Kuhajda FP . Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma. Clin Cancer Res 1997; 3: 2115–2120.

    CAS  Google Scholar 

  42. Rawson RB . The SREBP pathway–insights from Insigs and insects. Nat Rev Mol Cell Biol 2003; 4: 631–640.

    Article  CAS  Google Scholar 

  43. Porstmann T, Santos CR, Griffiths B, Cully M, Wu M, Leevers S et al. SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab 2008; 8: 224–236.

    Article  CAS  Google Scholar 

  44. Li W, Tai Y, Zhou J, Gu W, Bai Z, Zhou T et al. Repression of endometrial tumor growth by targeting SREBP1 and lipogenesis. Cell Cycle 2012; 11: 2348–2358.

    Article  CAS  Google Scholar 

  45. Ettinger SL, Sobel R, Whitmore TG, Akbari M, Bradley DR, Gleave ME et al. Dysregulation of sterol response element-binding proteins and downstream effectors in prostate cancer during progression to androgen independence. Cancer Res 2004; 64: 2212–2221.

    Article  CAS  Google Scholar 

  46. Calvisi DF, Wang C, Ho C, Ladu S, Lee SA, Mattu S et al. Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma. Gastroenterology 2011; 140: 1071–1083.

    Article  CAS  Google Scholar 

  47. Yamashita T, Honda M, Takatori H, Nishino R, Minato H, Takamura H et al. Activation of lipogenic pathway correlates with cell proliferation and poor prognosis in hepatocellular carcinoma. J Hepatol 2009; 50: 100–110.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The study was supported by research grants from ‘973‘ Project (No. 2012CB932604), New Drug Discovery Project (No. 2012ZX09506-001-005), Shanghai First-class Discipline (Medical technology), National Natural Science Foundation of China (No. 81372195, 81471685 and 81471687), Shanghai Pujiang Program (No. 13PJ1406000), Science and Technology Commission of Shanghai Municipality (No. 134119a5600), Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning (No. 1410000157) and Shanghai Municipal Commission of Health and Family Planning (XYQ2013109). FY was supported by NIH R01 (DK093623).

Author information

Author notes

  1. Z Zhu and X Zhao: These authors contributed equally to this work.

Authors and Affiliations

  1. Department of Nuclear Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

    Z Zhu, X Zhao, L Zhao, L Liu, J Li, J Wu, G Huang & J Liu

  2. Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

    H Yang & G Huang

  3. Department of Medicine and Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, New York, NY, USA

    F Yang

Authors
  1. Z Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. X Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. L Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. F Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. G Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. J Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to G Huang or J Liu.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on the Oncogene website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhu, Z., Zhao, X., Zhao, L. et al. p54nrb/NONO regulates lipid metabolism and breast cancer growth through SREBP-1A. Oncogene 35, 1399–1410 (2016). https://doi.org/10.1038/onc.2015.197

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2015.197

Search

Advanced search

Quick links